Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0711487B2 - Real-time determination method of colloid titration end point - Google Patents
[go: Go Back, main page]

JPH0711487B2 - Real-time determination method of colloid titration end point - Google Patents

Real-time determination method of colloid titration end point

Info

Publication number
JPH0711487B2
JPH0711487B2 JP15666089A JP15666089A JPH0711487B2 JP H0711487 B2 JPH0711487 B2 JP H0711487B2 JP 15666089 A JP15666089 A JP 15666089A JP 15666089 A JP15666089 A JP 15666089A JP H0711487 B2 JPH0711487 B2 JP H0711487B2
Authority
JP
Japan
Prior art keywords
titration
end point
color change
transmitted light
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP15666089A
Other languages
Japanese (ja)
Other versions
JPH0324445A (en
Inventor
千秋 五十嵐
Original Assignee
荏原インフイルコ株式会社
株式会社荏原総合研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 荏原インフイルコ株式会社, 株式会社荏原総合研究所 filed Critical 荏原インフイルコ株式会社
Priority to JP15666089A priority Critical patent/JPH0711487B2/en
Publication of JPH0324445A publication Critical patent/JPH0324445A/en
Publication of JPH0711487B2 publication Critical patent/JPH0711487B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、定量分析法の一つである変色指示薬を用いる
コロイド滴定法における、滴定終点の決定に関する。
TECHNICAL FIELD The present invention relates to determination of a titration end point in a colloid titration method using a color change indicator which is one of quantitative analysis methods.

〔従来の技術〕[Conventional technology]

滴定法において従来から用いられている滴定終点の決定
方法を第1図に示す。測定量(第1図では透過光量)と
滴定剤添加量との関係を求めた後、以下に示すいずれか
の定義に該当する点を演算もしくは作図により求めて滴
定終点としている。
FIG. 1 shows a conventional method for determining the end point of titration in the titration method. After determining the relationship between the measured amount (the amount of transmitted light in FIG. 1) and the amount of titrant added, a point corresponding to any of the following definitions is calculated or drawn to be the titration end point.

a)測定値が急激に変化し始める点−変曲点法 b)測定値が急激に変化する点の前後における測定量の
差を二等分割する点−二等分法 c)滴定剤添加量と測定値の関係を微分し、該微分値が
極大となる点−微分法 〔発明が解決しようとする問題点〕 従来の滴定終点決定方法には、以下の欠点がある。
a) A point at which the measured value starts to change rapidly-an inflection point method b) A point at which the difference in the measured amount before and after the point at which the measured value suddenly changes is divided into two equal parts-bisect method c) Amount of titrant added The difference between the measured value and the measured value is differentiated, and the differential value becomes maximum-differential method [Problems to be solved by the invention] The conventional titration end point determination method has the following drawbacks.

1)滴定操作終了後に、滴定終点を演算もしくは作図に
より決定するため、リアルタイムで終点決定ができな
い。
1) Since the titration end point is determined by calculation or drawing after the titration operation is completed, the end point cannot be determined in real time.

2)1)の理由により、分析操作がバッチ方式となり、
連続化しにくい。
2) Due to the reason 1), the analytical operation is a batch method,
It is difficult to make it continuous.

3)測定値の変曲点等を容易には自動判定できないた
め、終点決定のソフトウェアが複雑となり、分析機器が
高価になる。
3) Since the inflection point and the like of the measured value cannot be easily automatically determined, the software for determining the end point becomes complicated, and the analysis equipment becomes expensive.

4)変色反応を妨害する因子があり、滴定終点の精度が
低下する。たとえば、溶存塩類によって指示薬の変色が
不鮮明となる。
4) There are factors that interfere with the color change reaction, and the accuracy of the titration end point decreases. For example, the dissolved salts obscure the discoloration of the indicator.

一方、上述問題点を解決する一方法として、本出願人は
先に滴定開始前の指示薬添加時点での透過光量を計測
し、その量に所定の定数を乗じた値の透過光量を与える
滴定剤の添加量を滴定終点とするリアルタイム決定方法
を提案した(特開平1−116447号参照)。
On the other hand, as one method for solving the above-mentioned problems, the present applicant first measured the amount of transmitted light at the time of addition of the indicator before the start of titration, and gave a transmitted light amount of a value obtained by multiplying the amount by a predetermined constant. A real-time determination method has been proposed in which the addition amount of is determined as the end point of titration (see JP-A-1-116447).

しかしながら、この方法は、滴定終点を滴定曲線の変曲
域の初期に設定するため、滴定剤の添加量に対する透過
光量の変化が少なく、やや精度が悪い欠点があった。
However, in this method, the end point of titration is set at the initial stage of the inflection area of the titration curve, and therefore, there is a small change in the amount of transmitted light with respect to the amount of the titrant added, and the accuracy is somewhat poor.

本発明は、コロイド滴定における上記問題点を克服し、
溶存塩類等による妨害を受けず、しかもリアルタイムで
滴定終点を決定する、極めて簡単な方法を提供する。
The present invention overcomes the above problems in colloid titration,
(EN) An extremely simple method for determining a titration end point in real time without being disturbed by dissolved salts and the like.

〔問題点を解決するための手段〕[Means for solving problems]

上記問題点を解決するための考え方は、滴定終点におけ
る変色指示薬の変化状況をあらかじめ定義し、設定して
おくものである。すなわち、試料が滴定剤の添加につれ
て変化し、あらかじめ定義し設定しておいた変化状況に
なった時点で滴定終点を検知するリアルタイム決定方法
である。
The idea for solving the above problems is to predefine and set the change status of the color change indicator at the end point of titration. That is, it is a real-time determination method in which the titration end point is detected when the sample changes with the addition of the titrant, and when the change state is defined and set in advance.

本発明に用いられる変色指示薬としは、カルコン、トル
イジンブルーが挙げられる。
Examples of the color change indicator used in the present invention include chalcone and toluidine blue.

即ち、本発明は、変色指示薬を加えた検水を試薬を用い
て滴定し、変色指示薬の変色反応から滴定終点を求め検
水のコロイド荷電量を算出するコロイド滴定法におい
て、検水に光を照射し、変色指示薬の変色反応によって
透過光量の変化を生ずる波長領域内の2種の波長におけ
る透過光量が等しくなった時を滴定終点とするコロイド
滴定終点のリアルタイム決定方法及び該コロイド滴定法
において、検水に光を照射し、変色指示薬の変色反応に
おける2つの検知帯域の透過光量とその間に存在する等
吸収点の透過光量の何れか2つを検出し、両者の透過光
量が等しくなった時を滴定終点とするコロイド滴定終点
のリアルタイム決定方法である。
That is, the present invention is a colloid titration method in which the test water to which a color change indicator is added is titrated using a reagent, and the colloidal charge amount of the test water is calculated by determining the titration end point from the color change reaction of the color change indicator. In the colloidal titration method and the real-time determination method of the colloidal titration end point, when the irradiation is performed, the titration end point is the time when the transmitted light amounts at the two wavelengths in the wavelength region in which the change in the transmitted light quantity is caused by the color change reaction of the color change indicator are changed. When the test water is irradiated with light and any two of the transmitted light amounts of the two detection bands in the color change reaction of the color change indicator and the transmitted light amount of the isosbestic point existing between them are detected, and the transmitted light amounts of both become equal. Is a real-time method for determining the colloid titration end point.

等吸収点をその間に有する2つの検知帯域とは滴定剤添
加量に対応して透過光量の変化を生ずる実質的に可視光
の波長域の内、1つは等吸収点の波長より短い波長の領
域であり、他の1つは等吸収点の波長より長い波長の領
域を各々意味する。即ち、検知帯域は、具体的には、滴
定前と滴定終了後の2種の吸収ピークを形成する波長領
域が挙げられる。
Two detection zones having isosbestic points between them mean that one of wavelengths shorter than the wavelength of isosbestic points is within the wavelength range of substantially visible light that causes a change in the amount of transmitted light corresponding to the amount of titrant added. The other one means a region having a wavelength longer than the wavelength of the isosbestic point. That is, the detection zone specifically includes a wavelength region in which two types of absorption peaks are formed before and after titration.

本発明では、好ましくは、2種の波長領域の各々で任意
の波長を選定することにより、それら2種の透過光量を
求めることにより、あるいは等吸収点の波長とそれら2
つの検知帯域の波長の1つを求めることにより実施され
るが、1種の検知帯域内のみから検定のための該2波長
を選定することができる。
In the present invention, it is preferable to select an arbitrary wavelength in each of the two wavelength regions, determine the transmitted light amount of the two types, or to determine the wavelengths of the isosbestic point and the wavelengths of the two types.
It is carried out by determining one of the wavelengths of one detection band, but the two wavelengths for the assay can be selected from only one detection band.

該2波長の選択においては、実用上精度に支障を生じな
い範囲の波長巾(差)を有していることが望ましく、目
的に応じて適宜決定されるが、好ましくは、1nm以上、
特に好ましくは、10nm以上の差を有していることが良
い。
In the selection of the two wavelengths, it is desirable to have a wavelength width (difference) in a range that does not hinder the accuracy in practical use, and it is appropriately determined according to the purpose, but preferably 1 nm or more,
Particularly preferably, the difference is 10 nm or more.

本発明においては透過光量が等しくなった時とは、必ず
しも2種の透過光量の差が0である時のみを意味するも
のではなく、0の近辺の値になった時を滴定終点と定義
しても支障は生じない。
In the present invention, when the amount of transmitted light becomes equal does not necessarily mean only when the difference between the amounts of transmitted light of two types is 0, and the time when the value becomes close to 0 is defined as the titration end point. However, there is no problem.

本発明に用いられる装置としては、滴定剤としての試薬
供給管及び指示薬供給管を備えた検水を受容する容器、
検水に光を照射する発光部及び検水を透過した該所定の
2種の波長における光を各々受光し、それらを透過光出
力として電気信号に変える光量検出器から構成される。
The apparatus used in the present invention includes a container for receiving test water, which is provided with a reagent supply pipe as a titrant and an indicator supply pipe,
It is composed of a light emitting unit that irradiates the test water with light and a light amount detector that receives the light of the predetermined two types of wavelengths that has passed through the test water and converts them into electric signals as transmitted light outputs.

以下、本発明の具体的実施態様を第2図〜第4図を参照
して説明する。
Specific embodiments of the present invention will be described below with reference to FIGS. 2 to 4.

第2図は変色指示薬としてトルイジンブルーを、滴定剤
として所定濃度のポリビニール硫酸カリウム(PVSK)を
用いた所定検水の透過光出力曲線である。
FIG. 2 is a transmitted light output curve of a predetermined test water using toluidine blue as a discoloration indicator and a predetermined concentration of polyvinyl potassium sulfate (PVSK) as a titrant.

該検水はコロイド荷電がマイナスである試料に所定のカ
チオンコロイド標準液を添加し、試料全体のコロイド荷
電をプラスに調整して、逆滴定法により検定された。
The test water was assayed by a back titration method by adding a predetermined cation colloid standard solution to a sample having a negative colloidal charge and adjusting the colloidal charge of the entire sample to be positive.

検水に指示薬添加後、滴定剤添加前は該検水は青色を呈
し、中心波長が640nm近傍にある吸収ピークを持つ(図
中、滴定剤0μlのライン)。一方、滴定終了後は、検
水はピンク色になるが、中心波長が520nm近傍にある吸
収ピークをもつ(図中、滴定剤200μlのライン)。ま
た、両吸収ピーク波長の中間に、異なる滴定量において
も透過光量が略一定である等吸収点(550nm近傍)が存
在する。従って、本発明における検知帯域の1つは400n
m〜550nmの範囲、及び他の1つは550nm〜700nmの範囲で
ある。700nm附近にも等吸収点があるが、これは本発明
において、透過光量が等しくなる場合が無いから採用さ
れないことは明白である。即ち、滴定終点を与えるライ
ンは両ラインによって構成された八の字状の領域に存在
することになる。
After the addition of the indicator to the test water and before the addition of the titrant, the test water has a blue color and has an absorption peak with a central wavelength near 640 nm (in the figure, a line of 0 μl titrant). On the other hand, after the end of the titration, the test water turns pink, but it has an absorption peak with a central wavelength near 520 nm (in the figure, a line of the titrant 200 μl). Further, in the middle of both absorption peak wavelengths, there exists an isosbestic point (near 550 nm) where the amount of transmitted light is substantially constant even with different titration amounts. Therefore, one of the detection bands in the present invention is 400n
The range is from m to 550 nm, and the other is from 550 nm to 700 nm. Although there is an isosbestic point near 700 nm, it is obvious that this is not adopted in the present invention because the transmitted light amounts may not be equal. That is, the line giving the titration end point exists in the area of the figure eight formed by both lines.

この滴定終点を与える可能性のあるラインは従来定義し
た数だけ存在するが、本発明では、等吸収点を与える波
長を包含する、該八の字状の領域に対応する2種の波
長、特に、該2種の検知帯域の夫々から選定した波長及
び等吸収点を与える波長から選択した2種の波長におけ
る透過光量〔好ましくは、波長として、滴定前の主吸
収ピークの中心近傍の波長(640nm近傍)、滴定終了
後の主吸収ピークの中心近傍の波長(520nm近傍)およ
びその間に存在する等吸収点近傍の波長(550nm近
傍)の何れか2種の波長を選択した透過光量〕、即ち透
過光出力が等しい点を通るラインを滴定終点を与えるラ
インと定義することができ、そのラインが形成される時
の滴定剤の添加量を滴定終点とすればよい。この理由は
第3図により説明する。また、該2種の波長として、該
1種の検知帯域の中から2種を選定してもよい(例え
ば、選択範囲として、520nm〜550nmの範囲、550nm〜640
nmの範囲の各範囲が挙げられる)。
Although there are as many lines as previously defined that may give the titration end point, in the present invention, two wavelengths corresponding to the figure-eight region including the wavelength giving the isosbestic point, particularly , The amount of transmitted light at two wavelengths selected from the wavelengths selected from each of the two detection bands and the wavelength giving an isosbestic point [preferably, the wavelength near the center of the main absorption peak before titration (640 nm Near), the wavelength near the center of the main absorption peak after the titration (near 520 nm) and the wavelength near the isosbestic point existing between them (near 550 nm). A line that passes through points where the light outputs are equal can be defined as a line that gives a titration end point, and the amount of titrant added when the line is formed may be the titration end point. The reason for this will be described with reference to FIG. Also, as the wavelengths of the two types, two types may be selected from the detection band of the one type (for example, the selection range is 520 nm to 550 nm, 550 nm to 640 nm).
Each range of nm range is mentioned).

上記定義した滴定終点は従来法による定義の滴定終点と
一致する必要はない。
The titration endpoint defined above need not coincide with the titration endpoint defined by the conventional method.

といのは、コロイド滴定においては測定にさいして、別
にブランクテストをし、その測定値を本試験の測定値か
ら差し引き、その差の値から定量をしている。このため
本試験における滴定曲線上の滴定終点の取り方とブラン
クテストにおける滴定曲線上の滴定終点の取り方が同じ
であれば、従来法と本発明法においてその差の値は滴定
曲線の変曲域(なるべくは立ち上り直線部か又はそれに
近いところ)のどこで取っても同じになる。そしてその
差の値は、第3図に示した様に前記の従来の二等分法に
よった場合の本試験の滴定終点の滴定剤添加量とブラン
クテストの滴定終点の滴定剤添加量との差(Δb)と本
発明で定義した滴定終点を本試験およびブランクテスト
に適用した場合の差(例えばΔp,Δp′)とが等しい
(即ち、Δb=Δp=Δp′)ので、計算処理を要する
二等分法を取らなくても同じ結果が得られる。
The reason for this is that in colloid titration, a blank test is carried out separately during measurement, the measured value is subtracted from the measured value of the main test, and the difference is quantified. Therefore, if the method of taking the titration end point on the titration curve in this test and the way of taking the titration end point on the titration curve in the blank test are the same, the value of the difference between the conventional method and the method of the present invention is the inflection of the titration curve. It will be the same regardless of where it is taken in the area (preferably at the rising straight line or near it). The value of the difference is, as shown in FIG. 3, the titration agent addition amount at the titration end point of the main test and the titration agent addition amount at the titration end point of the blank test when the above-mentioned conventional bisection method is used. Difference (Δb) and the difference when the titration end point defined in the present invention is applied to the main test and the blank test (for example, Δp, Δp ′) are equal (that is, Δb = Δp = Δp ′). The same result is obtained without taking the required bisection method.

波長の選択は、現実的には、滴定終点の前後で変化する
割合の最も大きな組合せが精度を保つ上で好ましく、本
態様では、の640nm近傍との520nm近傍である。即
ち、2種の波長における透過光出力差(I630−I520)の
滴定剤添加量に対する勾配が大きい程、高精度である。
又、該差が0となる所が滴定終点を与えることになる。
この場合、滴定終点として該差が0mVでない±数mVの値
を滴定終点としても現実的に全く支障を生じ無い。この
様子をI520−I550及びI630−I550と共に第4図に示し
た。
In terms of wavelength selection, it is practically preferable that the combination with the largest rate of change before and after the titration end point is maintained in order to maintain accuracy, and in the present embodiment, the wavelength is in the vicinity of 640 nm and in the vicinity of 520 nm. That is, the greater the gradient of the transmitted light output difference (I 630 -I 520 ) at the two wavelengths with respect to the amount of titrant added, the higher the accuracy.
Also, the point where the difference becomes 0 gives the titration end point.
In this case, even if the difference is not 0 mV and a value of ± several mV is used as the end point of titration, no problem is caused practically. This state is shown in FIG. 4 together with I 520 -I 550 and I 630 -I 550 .

本態様は、トルイジンブルーの変色反応が青→紫になる
ように、滴定剤としてアニオン(PVSK)を選んだ場合で
ある。これはカチオン性の原水を測定する場合に用いら
れる。逆に滴定剤をカチオン(MGCh)とし、トルイジン
ブルーの変色反応が紫→青になるように利用することも
できるが、その場合は、滴定の進行によって測定値の増
減の方向は反対になる。分析の精度としては、トルイジ
ンブルーの変色反応を青→紫の方向(青色の消失)に用
いる方が、紫→青の方向に用いるよりもよいとされてい
る。
In this embodiment, an anion (PVSK) is selected as a titrant so that the color change reaction of toluidine blue changes from blue to purple. It is used when measuring cationic raw water. On the contrary, it is possible to use a cation (MGCh) as the titrant and use it so that the color change reaction of toluidine blue changes from purple to blue, but in that case, the direction of increase and decrease of the measured value becomes opposite as the titration proceeds. As for the accuracy of the analysis, it is said that using the discoloration reaction of toluidine blue in the blue → purple direction (disappearance of blue) is better than using it in the purple → blue direction.

又、変色反応を利用する指示薬として、アニオンコロイ
ドの滴定にはカルコンを用いることができる。この場合
には、滴定剤として正電荷をもつ塩化ポリジアリルジメ
チルアンモニウム(登録商標:CATFLOC,米国 カルゴン
社製)を用い、検出波長として吸収ピークの510nm近傍
もしくは665nm 近傍、等吸収点近傍560nmを用いるとよ
い。
Further, chalcone can be used for titration of anion colloid as an indicator utilizing the color change reaction. In this case, a positively charged polydiallyldimethylammonium chloride (registered trademark: CATFLOC, manufactured by Calgon Inc., USA) is used as a titrant, and an absorption peak near 510 nm or around 665 nm, near isobaric point near 560 nm is used as a detection wavelength. Good.

以上のように、2波長を比較して滴定終点を決定すると
試料の濁度、光源の光量、指示薬の添加量等の変動は、
キャンセルされることになり測定精度が向上する。
As described above, when the titration end point is determined by comparing the two wavelengths, variations in the turbidity of the sample, the light amount of the light source, the added amount of the indicator, etc.
It will be canceled and the measurement accuracy will be improved.

〔実施例〕〔Example〕

以下、実施例により本発明を具体的に説明する。本発明
はこれらの実施例のみに限定されるものではない。
Hereinafter, the present invention will be specifically described with reference to examples. The invention is not limited to these examples only.

実施例1 下水汚泥にカチオンポリマーを添加して凝集させ、ベル
トプレスで脱水して得た濾液を試料とし、指示薬として
トルイジンブルー、滴定剤としてポリビニール硫酸カリ
ウム(PVSK)を用いて、コロイド滴定を行ない、滴定終
点における滴定剤添加量を求めた。本発明の測定波長と
して吸収ピーク波長の635nm及び520nmを用いた。又、同
一試料を用いた従来法と比較した。結果を表−1に示
す。
Example 1 A cationic polymer was added to sewage sludge to cause coagulation, and the filtrate obtained by dehydration with a belt press was used as a sample, and toluidine blue was used as an indicator, and potassium polysulfate (PVSK) was used as a titrant to perform colloid titration. The amount of titrant added at the end of titration was determined. The absorption peak wavelengths of 635 nm and 520 nm were used as the measurement wavelengths of the present invention. In addition, a comparison was made with the conventional method using the same sample. The results are shown in Table-1.

表−1より、本発明は従来法より精度がよく測定時間も
短いことが分る。
From Table-1, it can be seen that the present invention has better accuracy and shorter measurement time than the conventional method.

実施例2 試料としてアニオンポリマー〔エバグロースA110(商品
名:荏原インフェルコ社製)、溶解濃度10mg/l〕を用
い、指示薬としてカルコン、滴定剤としてCATFLOCを用
いてコロイド滴定し、滴定終点における滴定剤添加量を
求めた。本発明の測定波長として、吸収ピーク波長の51
0nmと等吸収点波長の560nmを用いた。
Example 2 Colloidal titration using chalcone as an indicator and CATFLOC as a titrating agent using an anionic polymer [Ebagrose A110 (trade name: manufactured by Ebara Infelco), dissolution concentration 10 mg / l] as a sample, and a titration agent at the titration end point The amount added was determined. As the measurement wavelength of the present invention, the absorption peak wavelength of 51
A wavelength of 0 nm and an isosbestic point wavelength of 560 nm were used.

又、同一試料を用いた従来法と比較した。結果を表−2
に示す。
In addition, a comparison was made with the conventional method using the same sample. The results are shown in Table-2.
Shown in.

本発明によれば、従来法以上の精度で滴定点を短時間で
出力できる。
According to the present invention, the titration point can be output in a short time with higher accuracy than the conventional method.

〔発明の効果〕〔The invention's effect〕

本発明によれば、コロイド滴定の終点を、従来法以上の
精度で、しかもリアルタイムで求めることができる。そ
のため分析に要する測定時間が短くですむ。また、滴定
終点の決定に必要なソフトウェアは特に必要としないの
で、分析機器を安価に製作できる効果がある。
According to the present invention, the end point of colloid titration can be obtained with higher accuracy than the conventional method and in real time. Therefore, the measurement time required for analysis can be shortened. In addition, since software required for determining the titration end point is not particularly required, there is an effect that an analytical instrument can be manufactured at low cost.

【図面の簡単な説明】[Brief description of drawings]

第1図は従来の滴定法を説明するための図、第2図、第
3図及び第4図は本発明を説明するための図で、第2図
は、指示薬としてトルイジンブルーを用いた場合のPVSK
添加量相違による波長に対する透過光出力曲線の相違を
示す図であり、第3図は本発明で定義した滴定終点を説
明するための、滴定剤添加量に対する透過光量の滴定曲
線を示す図であり、第4図は本発明に用いられる2波長
の透過光出力を滴定剤添加量に対してプロットした図で
ある。
FIG. 1 is a diagram for explaining a conventional titration method, FIGS. 2, 3, and 4 are diagrams for explaining the present invention, and FIG. 2 is a case where toluidine blue is used as an indicator. PVSK
It is a figure which shows the difference of the transmitted light output curve with respect to the wavelength by the addition amount difference, and FIG. 3 is a figure which shows the titration curve of the transmitted light amount with respect to the titrant addition amount for explaining the titration end point defined by this invention. FIG. 4 is a diagram in which the transmitted light output of two wavelengths used in the present invention is plotted against the amount of titrant added.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】変色指示薬を加えた検水を試薬を用いて滴
定し、変色指示薬の変色反応から滴定終点を求め検水の
コロイド荷電量を算出するコロイド滴定法において、検
水に光を照射し、変色指示薬の変色反応によって透過光
量の変化を生ずる波長領域内の2種の波長における透過
光量が等しくなった時を滴定終点とするコロイド滴定終
点のリアルタイム決定方法。
1. A colloidal titration method in which a test water containing a color change indicator is titrated with a reagent, the end point of titration is determined from the color change reaction of the color change indicator, and the colloidal charge of the test water is calculated. A method for real-time determination of a colloidal titration end point, wherein the titration end point is when the transmitted light amounts at two wavelengths within the wavelength region that cause a change in the transmitted light amount due to the color change reaction of the color change indicator are equal.
【請求項2】変色指示薬を加えた検水を試薬を用いて滴
定し、変色指示薬の変色反応から滴定終点を求め検水の
コロイド荷電量を算出するコロイド滴定法において、検
水に光を照射し、変色指示薬の変色反応における2つの
検知帯域の透過光量とその間に存在する等吸収点の透過
光量の何れか2つを検出し、両者の透過光量が等しくな
った時を滴定終点とするコロイド滴定終点のリアルタイ
ム決定方法。
2. A colloid titration method in which the test water to which a color change indicator is added is titrated with a reagent, the end point of the titration is determined from the color change reaction of the color change indicator, and the colloidal charge of the test water is calculated. However, the colloid whose titration end point is when either of the two transmitted light amounts in the two detection zones in the color change reaction of the color change indicator and the transmitted light amount at the isosbestic point existing between them is detected, and when both transmitted light amounts become equal Real-time determination method of titration end point.
JP15666089A 1989-06-21 1989-06-21 Real-time determination method of colloid titration end point Expired - Lifetime JPH0711487B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15666089A JPH0711487B2 (en) 1989-06-21 1989-06-21 Real-time determination method of colloid titration end point

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15666089A JPH0711487B2 (en) 1989-06-21 1989-06-21 Real-time determination method of colloid titration end point

Publications (2)

Publication Number Publication Date
JPH0324445A JPH0324445A (en) 1991-02-01
JPH0711487B2 true JPH0711487B2 (en) 1995-02-08

Family

ID=15632514

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15666089A Expired - Lifetime JPH0711487B2 (en) 1989-06-21 1989-06-21 Real-time determination method of colloid titration end point

Country Status (1)

Country Link
JP (1) JPH0711487B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5151904B2 (en) * 2008-10-23 2013-02-27 株式会社三菱化学アナリテック Potentiometric titration method and potentiometric titration apparatus
CN120870445B (en) * 2025-09-26 2025-12-02 吉林市光大分析技术有限责任公司 A method for determining the endpoint of optical titration

Also Published As

Publication number Publication date
JPH0324445A (en) 1991-02-01

Similar Documents

Publication Publication Date Title
Trinder Colorimetric micro-determination of calcium in serum
US3723062A (en) Photoelectric endpoint detection
US4716118A (en) Method for determining ionic strength of a sample
Jones et al. Complexometric titration of calcium and magnesium by a semiautomated procedure
JPH0711487B2 (en) Real-time determination method of colloid titration end point
JPH02297045A (en) Quantitative measurement of chemical parameter for sample medium
Laitinen et al. Amperometric Titration of Calcium
Zitomer et al. Spectrophotometric Determination of Ammonia as Trichloramine.
Pal et al. Determination of cyanide based upon its reaction with colloidal silver in the presence of oxygen
US3771961A (en) Calcium assay and reagents therefor
JPH0545907B2 (en)
JPH0514855B2 (en)
WO2014174818A1 (en) Quantitative analyzing method for oxidant and quantitative analyzing instrument for oxidant
McCleskey Fluorometric Method for the Determination of Urea in Blood.
Olenin et al. Sols of silver nanoparticles as analytical reagents for the determination of active chlorine in water samples by spectrophotometry and photometric titration
Uesugi The spectrophotometric determination of scandium with chromal blue G
JP3545928B2 (en) Magnesium ion concentration measurement device
JPH0635968B2 (en) Method for continuous flow analysis of colloidal charge
JPH01116447A (en) Real-time decision of colloid titration ending point
CN220671363U (en) Analytical equipment of direct titration nitric acid concentration by acid-base indicator method
Katsube et al. Spectrophotometric Determination of Uranium with Sodium 2 ″, 6 ″-dichloro-4′-hydroxy-3, 3′-dimethylfuchsone-5, 5′-dicarboxylate
Ayun et al. Development of Spectrophotometry Method For Iodide Determination Based on I2-Starch Complex Formation with Hypochlorite as oxidator
Ueda et al. Titration analysis of calcium salts of organic acids using potentiometry and photometry
Bellomo et al. Semi-automatic end-point detection in the determination of total hardness in water
JPS6347639A (en) Apparatus for measuring concentration of hydrogen ion